Drug intelligence / Profile preview

selenomethionine

Development stage
Phase 3
Lead developer
SWOG Cancer Research Network
Modality
Small Molecules
Administration
Oral, Intravenous
01

Overview

Selenomethionine is a naturally occurring organic selenium compound where selenium replaces the sulfur atom in the amino acid methionine. It is the primary dietary form of selenium found in plants and is highly bioavailable. In the body, selenomethionine is non-specifically incorporated into proteins in place of methionine or converted into selenocysteine for the synthesis of functional selenoproteins. These selenoproteins, including glutathione peroxidase (GPx), thioredoxin reductase, and iodothyronine deiodinases, are essential for antioxidant defense, redox signaling, and thyroid hormone metabolism. Clinically, selenomethionine has been investigated for its ability to reduce thyroid peroxidase antibody (TPOAb) titers in patients with autoimmune thyroiditis (Hashimoto's) and for its potential role in cancer chemoprevention, particularly in prostate cancer and follicular lymphoma, by mitigating oxidative DNA damage and supporting immune function.

Brand names
Selenorm
Other names
selenomethionineL-selenomethionineSe-Met(S)-2-amino-4-(methylselanyl)butanoic acid
02

Targets

TXNRD2 (Thioredoxin reductase 2)GPX4 (Glutathione peroxidase 4)

Beyond the preview

Go deeper on selenomethionine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on selenomethionine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call